News Mylan recalls pricey US EpiPens, but cheaper version unaffec... More trouble for embattled Mylan.
News Charities unite to oppose NICE rare disease rules MPs to discuss controversial plan in special debate.
News Will the NHS force doctors to prescribe biosimilars? NHS authorities could begin to use the reimbursement system as a “stick” to ensure doctors prescribe cheaper biosimilar medicines amid varied uptake in different regions.
News Drug price crackdown imminent, says Trump President Donald Trump has issued a fresh threat against pharma, saying a drug price crackdown could be worked in to new healthcare reforms.
News Drug price controversies hit pharma's reputation Patient groups slam pharma over drug costs in latest survey.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
